| abstract |
The present invention relates to N- (triazoloazinyl) arylsulfonamide derivatives of formula (I) wherein: X is nitrogen or CY, W is alkoxy, halogen or hydrogen, Y is hydrogen or halogen, methoxy or methyl optionally substituted with fluorine; Z is alkoxy, alkylthio or optionally fluoro-substituted methyl, Q CH or nitrogen, H, halogen, alkoxycarbonyl or optionally substituted alkyl, alkoxy, alkenyloxy, alkynyloxy , alkylthio, 2-methyl-1,3-dioxolan-2-yl, B hydrogen, halogen, nitro, cyano, alkoxycarbonyl, alkylamino, dialkylamino, or -ER '', where E is oxygen or -S (O) m, where m is 0, 1 or 2, R 'is optionally substituted alkyl, alkenyl or alkynyl, D is hydrogen, halogen , alkyl, fluorinated methyl, methoxy, ethoxy, or B and D together are optionally substituted -CH2-O-, T is hydrogen, -SO2R, -C (O) R, -C (O) OR, - C (O) N (R +) 2 or - (CH 2) 2 -C (O) OR wherein R is optionally substituted alkyl, alkenyl or alkynyl, and R 'is hydrogen, alkyl, alkenyl or alkynyl means a group with certain restrictions. HE |